Marcus C. Mifflin

Marcus C. Mifflin

Auto-generated profile, based on publicly available information

Marcus C. Mifflin

Department of Chemistry, University of Utah, 315 South 1400 East, Salt Lake City, Utah 84112, United States

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2024 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GHGabriel Costa Alverni Da Hora
Gabriel Costa Alverni Da Hora
MOMyongin Oh
Myongin Oh
MMMarcus C. Mifflin
Marcus C. Mifflin
LDLori Digal
Lori Digal
ARAndrew George Roberts
Andrew George Roberts
JSJessica M.J. Swanson
Jessica M.J. Swanson

29 April 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
EKEdgar Dalles Keyes
Edgar Dalles Keyes
MMMarcus C. Mifflin
Marcus C. Mifflin
MAMaxwell J. Austin
Maxwell J. Austin
BABrighton J. Alvey
Brighton J. Alvey
LLLotfa H. Lovely
Lotfa H. Lovely
ARAndrew George Roberts
Andrew George Roberts

15 August 2023 in ACS Bio & Med Chem Au
Verified
Journal Article
Open access
KEKarsten A. S. Eastman
Karsten A. S. Eastman
MMMarcus C. Mifflin
Marcus C. Mifflin
POPaul F. Oblad
Paul F. Oblad
ARAndrew George Roberts
Andrew George Roberts
VBVahe Bandarian
Vahe Bandarian
Ribosomally produced and post-translationally modified polypeptides (RiPPs) are a diverse group of natural products that are processed by a variety of enzymes to their biologically relevant forms. PapB is a member of the radical S-adenosyl-l-methionine (rSAM) superfamily that introduces thioether cross-links between Cys and Asp residues in the PapA RiPP. We report that PapB has high tolerance for variations in the peptide substrate. Our results demonstrate that branched side chains in the thiol- and carboxylate-containing residues are processed and that lengthening of these groups to homocysteine and homoglutamate does not impair the ability of PapB to form thioether cross-links. Remarkably, the enzyme can even cross-link a peptide substrate where the native Asp carboxylate moiety is replaced with a tetrazole. We show that variations to residues embedded between the thiol- and carboxylate-containing residues are tolerated by PapB, as peptides containing both bulky (e.g., Phe) and charged (e.g., Lys) side chains in both natural L- and unnatural D-forms are efficiently cross-linked. Diastereomeric peptides bearing (2S,3R)- and (2S,3S)-methylaspartate are processed by PapB to form cyclic thioethers with markedly different rates, suggesting the enzymatic hydrogen atom abstraction event for the native Asp-containing substrate is diastereospecific. Finally, we synthesized two diastereomeric peptide substrates bearing E- and Z-configured γ,δ-dehydrohomoglutamate and show that PapB promotes addition of the deoxyadenosyl radical (dAdo•) instead of hydrogen atom abstraction. In the Z-configured γ,δ-dehydrohomoglutamate substrate, a fraction of the dAdo-adduct peptide is thioether cross-linked. In both cases, there is evidence for product inhibition of PapB, as the dAdo-adducts likely mimic the native transition state where dAdo• is poised to abstract a substrate hydrogen atom. Collectively, these findings provide critical insights into the arrangement of reacting species in the active site of the PapB, reveal unusual promiscuity, and highlight the potential of PapB as a tool in the development peptide therapeutics.

18 December 2023 in ACS Chemical Biology
Verified
Journal Article
Closed access
LDLori Digal
Lori Digal
SSShiela C. Samson
Shiela C. Samson
MSMark A. Stevens
Mark A. Stevens
AGAbhijit Ghorai
Abhijit Ghorai
HKHyungyu Kim
Hyungyu Kim
ARAndrew George Roberts
Andrew George Roberts